The PCP focuses on understanding the mechanisms responsible for prostate cancer progression, identifying potential targets for more effective therapies, prevention, diagnosis, and prognosis, and developing pre-clinical and clinical trials to evaluate the efficacy of interventions based on such targets.
Read more about the Prostate Cancer Program (PCP)
See Program Members
Elucidating mechanisms of androgen action to identify novel and effective therapeutic targets
Discovering new biomarkers to improve prostate cancer diagnosis and prognosis
Understanding the epidemiology of prostate cancer to facilitate cancer prevention
Therapeutic and chemoprevention clinical trials for prostate cancer